Sean: It really shouldn't come as any surprise th
Post# of 148147
(Total Views: 451)
Posted On: 05/28/2022 1:00:46 PM
Sean:
It really shouldn't come as any surprise that shareholders have once again been delivered underwhelming news regarding trial results for a critical catalyst in company/drug development.
To quote Lalezari " Cytodyn is the most inept company I've ever dealt with, hands down win the prize for most ineffectual group" - with the canning of NP ( and hopefully rid Kelly as well ) the new leadership can push something to the finish line- More than six years and still in holding pattern with HIV- Taken far too long for the next Humira to get into hands of physicians and patients
It really shouldn't come as any surprise that shareholders have once again been delivered underwhelming news regarding trial results for a critical catalyst in company/drug development.
To quote Lalezari " Cytodyn is the most inept company I've ever dealt with, hands down win the prize for most ineffectual group" - with the canning of NP ( and hopefully rid Kelly as well ) the new leadership can push something to the finish line- More than six years and still in holding pattern with HIV- Taken far too long for the next Humira to get into hands of physicians and patients
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼